STC2 and hepatocellular carcinoma: Besides, independ on AFP, some other indicators shown outstanding diagnostic value, for example, STC2 was upregulated in both tumors and serum of HCC patients, and has good diagnostic significance and could be used as a co-biomarker for AFP to detect early HCC (18).